Skip to Main Content

Paper Details

Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy.
Theranostics
90
2017
BMSC, BMSCs, bone marrow, bone marrow-derived mesenchymal stem cell, bone marrow-derived mesenchymal stem cells, colitis, goat, heart failure, human, human BMSCs, lung embolism, mice, mouse, mouse BMSCs, platelets, prothrombin, respiratory failure, thromboplastin, thrombosis, tissue factor
Author NameAffiliation
Zhihong DengXijing Hospital, Fourth Military Medical University
  • 1 - 1

Datasets

Release 1.2